This guidance outlines COVID-19 advice for commissioners and service providers involved in assisting people who are dependent on drugs or alcohol or both (PHE)
Bibliography: Interventions – Treatment
Clinical guidelines for use of depot buprenorphine (Buvidal® ) in the treatment of opioid dependence (PDF)
This Clinical Guideline has been developed to inform decision-making by clinicians prescribing and/or patients being treated with Buvidal® long-acting injected buprenorphine preparations (SMMGP)
Out of harm’s way (PDF)
This document has been written in response to one of eight recommendations in the West Midlands PCC’s Drugs Policy Report (2018), a report that adopts a new approach that is dictated by evidence and compassion and where the emphasis centres on harm reduction to help to lower crime, save money and support communities (West Midlands Police and Crime Commissioner)
Delivering health and care for people who sleep rough (PDF)
This research starts to answer the question of what needs to be in place for the delivery of joined-up services to a population of people sleeping rough – as a system, rather than a discrete collection of services (King’s Fund)
Scottish drug misuse database
Overview of Initial Assessments for Specialist Drug Treatment 2018/19 – A National Statistics publication for Scotland
The Special Commission of Inquiry into the Drug ‘Ice’
A list of report sections from NSW, Australia
Drug-related hospital emergency presentations in Europe: update from the Euro-DEN Plus expert network
This report presents the latest findings on drug-related hospital emergencies from a network of sentinel hospitals across Europe. Almost 24 000 emergency presentations were recorded at 32 sentinel hospitals over the first 4 years of the project (EMCDDA)
Access to hepatitis c treatment and care among people who inject drugs: failing people most disproportionately affected
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans (heoCoalition)
Release of First-Ever National Clinical Guidelines on Substance Use Disorders among Older Canadians
Canadian healthcare providers now have the tools they need to better support the prevention, assessment and treatment of older adults at risk of, or living with, substance use disorders Canadian Coalition for Seniors’ Mental Health (CCSMH)
Trends in drug-related hospitalisations in Australia, 1999-2018
Each year, the Australian Institute of Health and Welfare (AIHW) makes available to Drug Trends in-depth data on drug-related hospitalisations in Australia from the National Hospital Morbidity Database (NDARC)
Substance misuse treatment for young people: statistics 2018 to 2019
Alcohol and drug treatment data for under-18s from PHE’s National Drug Treatment Monitoring System – NDTMS (Public Health England)
Substance misuse treatment for adults: statistics 2018 to 2019
Statistics on alcohol and drug misuse treatment for adults from PHE’s National Drug Treatment Monitoring System (NDTMS)
HIV and people who inject drugs (PDF)
Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report (ecdc)
Road to Recovery (PDF)
Addiction in our society – the case for reform (Centre for Social Justice)
Hepatitis C interventions (PDF)
Organisations providing harm reduction services in Europe – analysis and examples (European Harm Reduction Network)
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2019 report (PDF)
The aim of the Unlinked Anonymous Monitoring (UAM) Survey of People Who Inject Drugs (PWID) is to monitor the prevalence and incidence of HIV, hepatitis B and hepatitis C infection, and associated injecting risk behaviour in people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines (Public Health England)
NIH establishes network to improve opioid addiction treatment in criminal justice settings
Ten clinical research centers will address gaps in accessing high-quality care
National Drug Treatment Reporting System 2011-2017 drug data
Latest figures from the Health Research Board show 63,303 cases* presented for treatment for problem drug use (excluding alcohol) between 2011 and 2017 (HRB, Ireland)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
Drug-Related Hospital Statistics Scotland 2017/18
This report describes the number of drug-related hospital stays, the number and characteristics of patients admitted to hospital, the substances involved and the geographical variations within Scotland (ISD)
- 1
- 2
- 3
- …
- 12
- Next Page »
